Dirk Hose

Gavi — Switzerland

Medicine · Health Sciences

63h-index13.5kcitations486works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(373), Protein Degradation and Inhibitors(144), Peptidase Inhibition and Analysis(55), Glycosylation and Glycoproteins Research(37), Ubiquitin and proteasome pathways(37)

Publications486 total

Increasing Trends of Minimal Residual Disease Measurement in Trials Focusing on Multiple Myeloma Treatment: A Systematic Analysis of Clinical Research Design From 2014 to 2025
European Journal Of Haematology·2026
Prognostic Impact of the Hevylite Assay in Patients With <scp>IgG</scp> or <scp>IgA</scp> Multiple Myeloma Treated Within the <scp>GMMG</scp> ‐ <scp>MM5</scp> Trial
European Journal Of Haematology·2025Open Access
CO198 Outcomes Measured in Multiple Myeloma Trials in the Past 10 Years: Focus on Minimal Residual Disease and Therapy Response
Value in Health·2025
Minimal Residual Disease–Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials
Journal of Clinical Oncology·2025· 26 citedOpen Access
Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma
Journal of Hematology & Oncology·2025Open Access
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma
Journal of Hematology & Oncology·2024· 3 citedOpen Access
Impact of Clonal Heterogeneity in Newly Diagnosed, Transplant-Eligible Multiple Myeloma - Subgroup Analysis of the GMMG HD6 Phase III Trial
Blood·2024Open Access
Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation
JCO Precision Oncology·2024· 1 citedOpen Access
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma—Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries
International Journal of Molecular Sciences·2024· 1 citedOpen Access
CD8+ CD28− regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study
Leukemia·2024· 2 citedOpen Access
Supplementary Table 1 from Modeling Myeloma Dissemination &lt;i&gt;In Vitro&lt;/i&gt; with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
Supplementary Video 3 from Modeling Myeloma Dissemination &lt;i&gt;In Vitro&lt;/i&gt; with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
FIGURE 4 from Modeling Myeloma Dissemination &lt;i&gt;In Vitro&lt;/i&gt; with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
FIGURE 5 from Modeling Myeloma Dissemination &lt;i&gt;In Vitro&lt;/i&gt; with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
Supplementary Table 3 from Modeling Myeloma Dissemination &lt;i&gt;In Vitro&lt;/i&gt; with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
FIGURE 1 from Modeling Myeloma Dissemination &lt;i&gt;In Vitro&lt;/i&gt; with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
Supplementary Figures 1-8 from Modeling Myeloma Dissemination &lt;i&gt;In Vitro&lt;/i&gt; with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
FIGURE 3 from Modeling Myeloma Dissemination &lt;i&gt;In Vitro&lt;/i&gt; with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
FIGURE 2 from Modeling Myeloma Dissemination &lt;i&gt;In Vitro&lt;/i&gt; with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
Data from Modeling Myeloma Dissemination &lt;i&gt;In Vitro&lt;/i&gt; with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
page 1 of 25Next →

Frequent Co-authors

Hartmut Goldschmidt(34), Bernard Klein(20), Anna Jauch(19), Anja Seckinger(19), Jérôme Moreaux(16), Thierry Rème(16), Uta Bertsch(12), Jens Hillengaß(12), John De Vos(12), Kai Neben(11), Axel Benner(10), Thomas Hielscher(9), Anthony D. Ho(9), Michael Hundemer(9), Jean‐François Rossi(8), Pieter Sonneveld(7), Karène Mahtouk(7), Bronno van der Holt(6), Marc S. Raab(6), Alboukadel Kassambara(6)